Novo Nordisk A/S: Degludecplus Provides Superior Glycaemic Control Compared to Insulin Glargine in a Phase 3a Trial in Japanese People with Type 2 Diabetes

BAGSVAERD, DENMARK--(Marketwire - November 07, 2011) -

Company Announcement no 70 / 2011: http://hugin.info/2013/R/1561488/483284.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novo Nordisk A/S via Thomson Reuters ONE

[HUG#1561488]